By
48 min ago 2 min read
UK membrane-less electrolyser firm Clean Power Hydrogen (CPH2) will abandon manufacturing ambitions after it halted factory acceptance tests of its flagship 1MW commercial unit due to a system failure.
The Doncaster-based firm said the incident, which occurred during a “standard shutdown procedure” at , had caused damage beyond repair to its MFE220 unit.
While the exact cause remains under investigation, CPH2 said its Chief Technical Officer and Chief Operations Director concluded the unit will require “substantial redesign” to ensure “the mixed gas system can be operated safely in all conditions.”
Membrane-less electrolysers operate without a physical membrane and instead use fluid dynamics or buoyancy to separate hydrogen and oxygen. While the technology can offer improved flexibility, the potential for gases to mix creates complexity around safety and purity.
“Whilst the board retains confidence in the potential of the technology, it has concluded that the company does not have the financial, engineering, or technical resources to undertake such a programme at this time,” the company said.
It confirmed it would not recommence factory acceptance tests for the MFE220 system and instead “pursue alternative, non-manufacturing, commercial strategies.”
According to the company statement, its board believes existing IP, licensees, copyrights, and commercial relations have “significant commercial value.”
“The company is now actively evaluating options to maximise the value from its IP and related assets…which will be in the best interests of shareholders and other stakeholders.”
It comes as a major blow to the company which had been lining up commercial deployments of the MFE 220 system.
It had secured contracts to supply three further 1MW units to New Zealand-based Fabrum, and Ireland-based Lisheen H2 Energy Park, which also holds a license to of the units in Ireland.
In April, CPH2 revealed it would explore allowing a US firm to of its systems for sale in North America.
